Home
/
Odyssey Health, Inc.
/
Financials
/
Quarterly
Odyssey Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Odyssey Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Apr 30, 2020
$0
Nov 13, 2020
Q2
2020
Jan 31, 2020
$0
Nov 13, 2020
Q1
2020
Oct 31, 2019
$0
Nov 13, 2020
Q3
2020
Apr 30, 2019
$0
Nov 13, 2020
Q2
2020
Jan 31, 2019
$0
Nov 13, 2020
Q1
2020
Oct 31, 2018
$0
Nov 13, 2020
Q3
2019
Apr 30, 2018
$0
Jun 7, 2019
Q2
2019
Jan 31, 2018
$0
Mar 14, 2019
Q1
2019
Oct 31, 2017
$0
Mar 13, 2019
Q3
2018
Apr 30, 2017
$0
Aug 7, 2018
Q2
2018
Jan 31, 2017
$0
May 30, 2018
Q1
2018
Oct 31, 2016
$0
Dec 20, 2017
Q3
2017
Apr 30, 2016
$22.5K
Jun 21, 2017
Q2
2017
Jan 31, 2016
$0
Mar 23, 2017
Q1
2017
Oct 31, 2015
$0
Dec 20, 2016
Q3
2016
Apr 30, 2015
$18.0K
Jun 16, 2016
Q2
2016
Jan 31, 2015
$100.9K
Mar 15, 2016
Q1
2016
Oct 31, 2014
$138.3K
Dec 22, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
($3.60M)
Mar 12, 2026
Q1
2026
Oct 31, 2025
($483.4K)
Dec 11, 2025
Q2
2026
Oct 31, 2025
($483.4K)
Mar 12, 2026
Q3
2025
Apr 30, 2025
($251.7K)
Jun 13, 2025
Q3
2025
Jan 31, 2025
($220.1K)
Jun 13, 2025
Q2
2026
Jan 31, 2025
($220.1K)
Mar 12, 2026
Q1
2026
Oct 31, 2024
($1.02M)
Dec 11, 2025
Q3
2025
Oct 31, 2024
($1.02M)
Jun 13, 2025
Q2
2026
Oct 31, 2024
($1.02M)
Mar 12, 2026
Q3
2025
Apr 30, 2024
($842.3K)
Jun 13, 2025
Q2
2025
Jan 31, 2024
$13.28M
Mar 14, 2025
Q3
2025
Jan 31, 2024
$13.28M
Jun 13, 2025
Q2
2025
Oct 31, 2023
($538.0K)
Mar 14, 2025
Q1
2025
Oct 31, 2023
($538.0K)
Dec 16, 2024
Q3
2025
Oct 31, 2023
($538.0K)
Jun 13, 2025
Q3
2024
Apr 30, 2023
($1.28M)
Jun 14, 2024
Q3
2024
Jan 31, 2023
($1.67M)
Jun 14, 2024
Q2
2024
Jan 31, 2023
($1.67M)
Mar 22, 2024
Q1
2024
Oct 31, 2022
($2.15M)
Dec 15, 2023
Q3
2024
Oct 31, 2022
($2.15M)
Jun 14, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Jan 31, 2026
($181.9K)
Mar 12, 2026
Q1
2026
Oct 31, 2025
($303.2K)
Dec 11, 2025
Q3
2025
Apr 30, 2025
($129.1K)
Jun 13, 2025
Q2
2026
Jan 31, 2025
($156.6K)
Mar 12, 2026
Q1
2026
Oct 31, 2024
($579.4K)
Dec 11, 2025
Q3
2025
Apr 30, 2024
($372.4K)
Jun 13, 2025
Q2
2025
Jan 31, 2024
($1.16M)
Mar 14, 2025
Q1
2025
Oct 31, 2023
($347.2K)
Dec 16, 2024
Q3
2024
Apr 30, 2023
($1.09M)
Jun 14, 2024
Q2
2024
Jan 31, 2023
($1.49M)
Mar 22, 2024
Q1
2024
Oct 31, 2022
($2.08M)
Dec 15, 2023
Q3
2023
Apr 30, 2022
($2.87M)
Jun 14, 2023
Q2
2023
Jan 31, 2022
($1.98M)
Mar 17, 2023
Q1
2023
Oct 31, 2021
($1.43M)
Dec 14, 2022
Q3
2022
Apr 30, 2021
($12.09M)
Jun 14, 2022
Q2
2022
Jan 31, 2021
($633.8K)
Mar 15, 2022
Q1
2022
Oct 31, 2020
($525.3K)
Dec 10, 2021
Q3
2021
Apr 30, 2020
($867.7K)
Jun 21, 2021
Q2
2021
Jan 31, 2020
($499.8K)
Mar 11, 2021
Q1
2020
Oct 31, 2019
($1.32M)
Dec 11, 2020